The Manufacturers Life Insurance Company Purchases New Position in Inspire Medical Systems, Inc. $INSP

The Manufacturers Life Insurance Company acquired a new position in Inspire Medical Systems, Inc. (NYSE:INSP) during the second quarter, Holdings Channel reports. The institutional investor acquired 20,525 shares of the company’s stock, valued at approximately $916,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new stake in Inspire Medical Systems in the second quarter valued at approximately $211,341,000. Wellington Management Group LLP acquired a new position in shares of Inspire Medical Systems during the 4th quarter worth $203,929,000. Deerfield Management Company L.P. raised its holdings in shares of Inspire Medical Systems by 648.4% during the 3rd quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock valued at $77,739,000 after purchasing an additional 907,694 shares in the last quarter. Morgan Stanley lifted its stake in shares of Inspire Medical Systems by 179.5% in the 4th quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock valued at $116,188,000 after purchasing an additional 809,121 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. acquired a new stake in shares of Inspire Medical Systems in the 4th quarter valued at $61,619,000. Institutional investors own 94.91% of the company’s stock.

Analysts Set New Price Targets

INSP has been the topic of several analyst reports. Royal Bank Of Canada reissued a “sector perform” rating and set a $60.00 target price on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Bank of America cut Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 price target for the company. in a research report on Friday, May 22nd. Mizuho upped their price target on Inspire Medical Systems from $55.00 to $65.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 4th. Truist Financial reissued a “hold” rating and set a $62.00 price objective (up from $54.00) on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Finally, KeyCorp reissued a “sector weight” rating on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Two analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Inspire Medical Systems presently has a consensus rating of “Hold” and a consensus target price of $66.19.

Inspire Medical Systems Stock Up 1.4%

INSP stock opened at $62.99 on Friday. Inspire Medical Systems, Inc. has a twelve month low of $38.91 and a twelve month high of $147.03. The company has a market cap of $1.82 billion, a PE ratio of 13.63, a price-to-earnings-growth ratio of 4.79 and a beta of 0.70. The business’s 50-day simple moving average is $55.05 and its 200 day simple moving average is $52.43.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.14 EPS for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The firm had revenue of $200.58 million during the quarter, compared to analysts’ expectations of $194.72 million. During the same quarter in the prior year, the firm posted $0.45 EPS. The company’s revenue for the quarter was down 7.6% on a year-over-year basis. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Insider Activity

In related news, insider Jason Kelly sold 963 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the transaction, the insider directly owned 18,985 shares in the company, valued at approximately $1,130,556.75. This represents a 4.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.